Navigation Links
Global Med Technologies(R) Inc. Receives Unsolicited Proposal From Victory Park Capital Advisors, LLC
Date:12/9/2008

DENVER, Dec. 9 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that on Tuesday, December 9, 2008, its board of directors received a letter from Victory Park Capital Advisors, LLC ("VPC") whereby VPC proposed to acquire a majority share in, or full ownership of, Global Med. The proposal received is as follows:

    December 9, 2008

    Global Med Technologies, Inc.
    12600 West Colfax
    Suite C-420
    Lakewood, CO 80215

    To the Board of Directors (the "Board"):

Victory Park Capital Advisors, LLC ("VPC" or "we") has been an investor in Global Med Technologies, Inc. ("GLOB" or the "Company") since September 2007. In addition, certain principals of VPC have been involved with investments in GLOB since December 2005 while managing investments for a previous fund. VPC currently owns the following GLOB securities: (i) 5,500 preferred equity securities convertible into 5,500,000 shares of common equity at a conversion price of $0.72 per share; (ii) 4,125,000 warrants exercisable into 4,125,000 shares of common equity at a strike price of $0.72 per share; and (iii) 4,876,765 shares of common equity which were accumulated primarily through open market purchases. Currently, on an as-converted, fully-diluted basis we own approximately 29% of the economic interests in the Company.

Since first undertaking our investment in GLOB, we have continued to be actively and constructively involved in the Company's success. Over the last three years, the principals of VPC have completed, amongst other initiatives, the following:

    1.  waived various rights under our preferred equity security in order to
        facilitate numerous operational and strategic initiatives;
    2.  offered $9,000,000 in debt financings to facilitate two strategic
        acquisitions;
    3.  introduced the Company to Ken Hunt, a current Board member and
        shareholder;
    4.  assisted the Company in expanding its relationship with the Red Cross;
    5.  introduced GLOB to additional institutional investors (including both
        mutual funds and hedge funds) which purchased shares of common equity;
        and
    6.  assembled a syndicate of then current and new investors to purchase
        over 3,300,000 shares of common equity and common equity equivalents
        from the Company's then-largest and highly dissident shareholder.

Unfortunately, even with VPC's loyal strategic and financial support, the Company has been unable to realize full value as a publicly-traded company. If the equity markets do not reflect the Company's intrinsic value, we believe it is incumbent upon the Board to take action to realize that value for shareholders. Failure to act would only further destroy shareholder value as the Company continues to incur the onerous and increasing expenses of being a publicly-traded company.

Therefore, we believe the time has come to explore strategic alternatives, including a:

    1.  public auction of the Company for sale to a strategic or financial
        buyer; or
    2.  buyout transaction led by VPC.

VPC is prepared to purchase all of the Company's outstanding equity securities that VPC does not already own for $1.10 per share in cash, subject to the completion of limited, confirmatory due diligence, the negotiation of a definitive merger agreement and management cooperation. It is our intention to work closely with the Board to finalize the appropriate financing package necessary to successfully execute our intentions to operate the Company as a privately-held entity. We are prepared to move expeditiously to complete due diligence and begin discussions regarding appropriate transaction agreements.

We look forward to a productive process as we work with the Board to deliver full value to the Company's shareholders. We respectfully request that the Board respond to this letter no later than December 16, 2008.

    Sincerely,

    Richard Levy
    Managing Principal
    Victory Park Capital Advisors, LLC

The Board is reviewing the proposal and does not have any comment with respect to the proposal at this time.

About Global Med Technologies(R), Inc.

Global Med Technologies, Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.

Global Med's domestic companies are Wyndgate Technologies(R), which provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products; eDonor(R), which provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals; and PeopleMed(TM), Inc., which implements cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SapaNet.

For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com, http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.

*FDA 510(k) clearance required prior to sales in the U.S.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden
2. Childrens cancer group recommends global evaluation system for neuroblastoma to improve treatment
3. Former Mayor of Indianapolis to Serve as a Senior Strategic Advisor to McKenna Long & Aldridge LLPs Global Infrastructure Finance and Public-Private Partnerships Practice
4. Lilly Global Day of Service Receives National and Local Recognition
5. Community Unites for Physicians for Human Rights Town Meeting on Global AIDS and Human Rights on December 8
6. MetLife Mexico Life Insurance Company Partners with Assist America for Global Emergency Medical Assistance Services
7. Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices
8. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
9. Global Measles Deaths Drop By 74%
10. Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources Private Sourcing Events
11. Jolie-Pitt Foundation Awards Second Grant to Global Action for Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: